^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

MIR345 (MicroRNA 345)

i
Other names: MIR345, MicroRNA 345, Hsa-MiR-345-5p, Hsa-Mir-345, MIRN345, Hsa-Mir-345_pre, Hsa-MiR-345-3p, MIMAT0022698, MIMAT0000772, MI0000825, Mir-345, RF01044
Associations
3d
miRNA-mRNA integrative profiling in canine tubulopapillary mammary carcinoma. (PubMed, Res Vet Sci)
Among the differentially expressed mRNAs, we identified 360 mRNAs that were targets of the differentially expressed miRNAs, which enriched 23 biological pathways, with the "Endocytosis" pathway being of particular significance. These findings highlight the complex interactions between mRNAs and miRNAs in tubulopapillary CMTs, thereby improving the understanding of the pathophysiology of this CMT subtype and providing targets for functional validation of biomarkers and/or therapeutics.
Journal
|
MIR345 (MicroRNA 345)
2ms
Integrated transcriptomics and miRNA-mRNA network analysis reveals Kisspeptin-10 mediated regulation of EMT and apoptosis in glioblastoma. (PubMed, Comput Biol Chem)
These findings highlight the diagnostic and therapeutic relevance of Kisspeptin-10-associated molecular regulation in GB. This is the first study to integrate transcriptomics, miRNA-mRNA network analysis, and experimental validation to elucidate Kisspeptin-10-mediated modulation of GB progression.
Journal
|
CDC20 (Cell Division Cycle 20) • CDK1 (Cyclin-dependent kinase 1) • FABP5 (Fatty Acid Binding Protein 5) • MIR200 (MicroRNA 200) • MIR345 (MicroRNA 345)
4ms
Study of plasma exosomal miRNAs as novel biomarkers for differentiating primary central nervous system lymphoma and glioblastoma. (PubMed, BMC Cancer)
The increased expression level of EGFR in GBM may be achieved by the negative regulatory effects of miR-4433b-5p. The diagnostic performance of the miRNA biomarkers still needs to be further verified in larger sample size cohorts.
Journal
|
EGFR (Epidermal growth factor receptor) • MIR148A (MicroRNA 148a) • MIR345 (MicroRNA 345)
|
EGFR expression
6ms
Machine Learning Approach Identifies miRNA Biomarkers for Post Surgical Patient Stratification in Prostate Cancer. (PubMed, Prostate)
Our study presents a miRNA-based machine learning model that distinguishes metastatic from non-metastatic prostate cancer patients following surgery. The panel's alignment with CAPRA underscores its clinical relevance and highlights its potential for integration into future clinical frameworks.
Journal
|
MIR200A (MicroRNA 200a) • MIR182 (MicroRNA 182) • MIR769 (MicroRNA 769) • MIR106B (MicroRNA 106b) • MIR183 (MicroRNA 183) • MIR194 (MicroRNA 194) • MIR345 (MicroRNA 345)
7ms
Hepatoma-derived growth factor and non-coding RNA network in ovarian cancer patients. (PubMed, Biochem Biophys Rep)
HDGF may serve as a clinically relevant biomarker for disease progression, while LINC00839 and miR-345-5p represent promising therapeutic targets. These findings provide a foundation for future investigations into ceRNA-based diagnostics and treatments in OC.
Journal
|
MUC16 (Mucin 16, Cell Surface Associated) • HDGF (Heparin Binding Growth Factor) • MIR345 (MicroRNA 345)
7ms
Journal
|
SNHG5 (Small Nucleolar RNA Host Gene 5) • MIR345 (MicroRNA 345) • SNHG15 (Small Nucleolar RNA Host Gene 15)
9ms
Hypoxia-induced exosomal lncRNA-PVT1 as a biomarker and mediator of EMT in hepatocellular carcinoma. (PubMed, Oncol Res)
Plasma exosomal lncRNA-PVT1 expression is upregulated in highly invasive cells post-hypoxia, potentially serving as a biomarker for evaluating liver cancer prognosis after TACE. Through a miRNA-345-5p-mediated competing endogenous RNA mechanism, it promotes EMT in poorly invasive cells, likely contributing to recurrence and metastasis post-HCC interventional embolization.
Journal
|
CDH1 (Cadherin 1) • VIM (Vimentin) • FOXM1 (Forkhead Box M1) • MMP9 (Matrix metallopeptidase 9) • PVT1 (Pvt1 Oncogene) • MIR345 (MicroRNA 345)
9ms
[Retracted] MicroRNA‑345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1. (PubMed, Oncol Rep)
The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 38: 843‑849, 2017; 10.3892/or.2017.5772].
Journal
|
YAP1 (Yes associated protein 1) • MIR345 (MicroRNA 345)
over1year
Exosomal miRNAs as Participators of Hexavalent Chromium-Induced Genotoxicity and Immunotoxicity: A Two-Stage Population Study. (PubMed, Environ Sci Technol)
Although our findings suggested a link between extracellular miRNAs and immunosuppressive biomarkers, this association did not achieve validation in the external cohort, possibly due to population heterogeneity. Collectively, this study advanced our understanding of the epigenetic orchestration of health hazards of Cr(VI) by exosomal miRNAs, shedding light on their expression signatures and their intricate interplay with Cr(VI)-induced genetic and immunological perturbations, thus providing novel perspectives on the toxic pathways of heavy metals.
Journal • PD(L)-1 Biomarker • IO biomarker
|
PD-1 (Programmed cell death 1) • MIR206 (MicroRNA 206) • MIR4467 (MicroRNA 4467) • MIR345 (MicroRNA 345)
|
PD-1 expression
over1year
Expression profile of microRNAs in bovine lymphocytes infected with Theileria annulata and treated with buparvaquone. (PubMed, Parasitol Res)
MAPKAPK2, RELB, FLT3LG, and GADD45B were mainly enriched in the MAPK signaling pathway, and some genes were enriched in Axon guidance. This study has provided valuable information to further the understanding of the regulatory function of miRNAs in the host microenvironment and host-parasite interaction mechanisms.
Journal
|
MIR34A (MicroRNA 34a-5p) • SOCS1 (Suppressor Of Cytokine Signaling 1) • MIR584 (MicroRNA 584) • FLT3LG (Fms Related Receptor Tyrosine Kinase 3 Ligand) • GADD45B (Growth Arrest And DNA Damage Inducible Beta) • MIR150 (MicroRNA 150) • MIR345 (MicroRNA 345) • MIR622 (MicroRNA 622)
over1year
Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer (clinicaltrials.gov)
P=N/A, N=100, Enrolling by invitation, American University of Beirut Medical Center | Trial completion date: Apr 2024 --> Jul 2026 | Trial primary completion date: Dec 2023 --> Jul 2025
Trial completion date • Trial primary completion date • Metastases
|
MIR200C (MicroRNA 200c) • MIR31 (MicroRNA 31) • CRP (C-reactive protein) • MIR19A (MicroRNA 19a) • MIR203A (MicroRNA 203a) • MIR29A (MicroRNA 29a) • MIR345 (MicroRNA 345)
almost2years
Exosomal circ_0000735 contributes to non-small lung cancer malignant progression. (PubMed, J Biochem Mol Toxicol)
In addition, exosomes mediated the intercellular transmission of circ_0000735, and serum exosomal circ_0000735 might be an important indicator for the diagnosis of NSCLC. In conclusion, circ_0000735 facilitated NSCLC progression via miR-345-5p/ADAM19 pathway, and serum exosomal circ_0000735 might be a potential biomarker for NSCLC diagnosis.
Journal
|
ADAM9 (ADAM Metallopeptidase Domain 9) • MIR345 (MicroRNA 345)
|
ADAM9 expression • ADAM9 overexpression